Market Research Logo

Global Hypertension Epidemiology and Patient Flow Analysis - 2017

1. Hypertension: Disease Definition
2. Global Hypertension Patient Flow
2A. Global Hypertension Prevalence
2B. Global Hypertension Diagnosed Patients
2C. Global Hypertension Treated Patients
3. Hypertension Patient Flow in the US
3A. Hypertension Prevalence in the US
3B. Hypertension Diagnosed Patients in the US
3C. Hypertension Treated Patients in the US
4. Hypertension Patient Flow in Europe
4A. Hypertension Prevalence in Europe
4B. Hypertension Diagnosed Patients in Europe
4C. Hypertension Treated Patients in Europe
5. Hypertension Patient Flow in Germany
5A. Hypertension Prevalence in Germany
5B. Hypertension Diagnosed Patients in Germany
5C. Hypertension Treated Patients in Germany
6. Hypertension Patient Flow in France
6A. Hypertension Prevalence in France
6B. Hypertension Diagnosed Patients in France
6C. Hypertension Treated Patients in France
7. Hypertension Patient Flow in Spain
7A. Hypertension Prevalence in Spain
7B. Hypertension Diagnosed Patients in Spain
7C. Hypertension Treated Patients in Spain
8. Hypertension Patient Flow in Italy
8A. Hypertension Prevalence in Italy
8B. Hypertension Diagnosed Patients in Italy
8C. Hypertension Treated Patients in Italy
9. Hypertension Patient Flow in UK
9A. Hypertension Prevalence in UK
9B. Hypertension Diagnosed Patients in UK
9C. Hypertension Treated Patients in UK
10. Hypertension Patient Flow in Japan
10A. Hypertension Prevalence in Japan
10B. Hypertension Diagnosed Patients in Japan
10C. Hypertension Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Hypertension Patient Flow, 2016
Table 2: Global Hypertension Patient Flow Forecast, 2016 - 2025
Table 3: Hypertension Patient Flow in the US, 2016
Table 4: Hypertension Patient Flow Forecast in the US, 2016 - 2025
Table 5: Hypertension Patient Flow in Europe, 2016
Table 6: Hypertension Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Hypertension Patient Flow in Germany, 2016
Table 8: Hypertension Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Hypertension Patient Flow in France, 2016
Table 10: Hypertension Patient Flow Forecast in France, 2016 - 2025
Table 11: Hypertension Patient Flow in Spain, 2016
Table 12: Hypertension Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Hypertension Patient Flow in Italy, 2016
Table 14: Hypertension Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Hypertension Patient Flow in UK, 2016
Table 16: Hypertension Patient Flow Forecast in UK, 2016 - 2025
Table 17: Hypertension Patient Flow in Japan, 2016
Table 18: Hypertension Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Hypertension Patient Flow, 2016
Figure 2: Global Hypertension Patient Flow Forecast, 2016 - 2025
Figure 3: Hypertension Patient Flow in the US, 2016
Figure 4: Hypertension Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Hypertension Patient Flow in Europe, 2016
Figure 6: Hypertension Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Hypertension Patient Flow in Germany, 2016
Figure 8: Hypertension Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Hypertension Patient Flow in France, 2016
Figure 10: Hypertension Patient Flow Forecast in France, 2016 - 2025
Figure 11: Hypertension Patient Flow in Spain, 2016
Figure 12: Hypertension Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Hypertension Patient Flow in Italy, 2016
Figure 14: Hypertension Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Hypertension Patient Flow in UK, 2016
Figure 16: Hypertension Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Hypertension Patient Flow in Japan, 2016
Figure 18: Hypertension Patient Flow Forecast in Japan, 2016 - 2025

Global Hypertension Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Hypertension patients study in a new report ‘Global Hypertension Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Hypertension epidemiology, Hypertension diagnosed patients, and Hypertension treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Hypertension derived from epidemiological analysis, percentage of patients diagnosed with Hypertension, and percentage of patients treated with a therapy.

The study helps executives estimate Hypertension market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Hypertension prevalence, Hypertension diagnosis rate, and Hypertension treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Hypertension Patient Flow
  • Hypertension Prevalence
  • Hypertension Diagnosed Patients
  • Hypertension Treated Patients


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;